The National Plan to address Alzheimer’s, set forth by the President of the United States, has set a goal to provide accurate diagnostic testing and effective treatments for individuals with symptoms of Alzheimer’s Dementia by 2025. The 2015 Alzheimer’s Association International Conference reported very promising data from the ongoing Alzheimer’s research trials. Many of these new investigational agents may provide cognitive stability.


The Compass Clinic is a partner of the Bioclinica Research Site Network.  With this partnership, The Compass Clinic offers the opportunity to its patients to be a part of groundbreaking research in the following conditions:


  • Mild Cognitive Impairment
  • Alzheimer's Disease
  • Parkinson's Disease
  • Essential Tremors
  • Alzheimer's Disease Prevention


To find out which studies are enrolling click here.

Matthew Bubalo, MA, LMHC​
Lead Community Liaison


​​Matt is responsible for assessing patients’ eligibility for clinical research trials.  He often meets with patients during their visit to the Compass Clinic to discuss research options, and helps connect our practitioners to the research clinic in a variety of ways.  In 2010, Matt began working at Bioclinica Research performing cognitive testing and recruiting patients from the community.  He is a licensed mental health counselor and has experience in acute psychiatric settings as well as outpatient counseling.  He graduated from Miami University of Ohio with a BA in psychology, and obtained an MA in clinical mental health counseling from Rollins College.

In order to better assist our patients, Matthew Bubalo is conveniently available in our office to discuss current research studies. You can reach him by calling 407-210-1320.

Research